Why a randomized melanoma screening trial may be a good idea

A E Cust^{1

2}, J F Aitken^{3

4}, P D Baade^{3

5}, D C Whiteman⁶, H P Soyer^{7

8}, M Janda⁹

Affiliations

¹ Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia.
² Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
³ Cancer Council Queensland, Brisbane, Australia.
⁴ Menzies Health Institute, Griffith University, Southport, QLD, Australia.
⁵ School of Mathematical Sciences, Queensland University of Technology, Brisbane, Australia.
⁶ QIMR-Berghofer Medical Research Institute, Brisbane, Australia.
⁷ Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia.
⁸ Dermatology Department, Princess Alexandra Hospital, Brisbane, Australia.
⁹ Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.

Comment

A E Cust et al. Br J Dermatol. 2018 Nov.

. 2018 Nov;179(5):1227-1228.

doi: 10.1111/bjd.17089. Epub 2018 Sep 20.

A E Cust^{1

2}, J F Aitken^{3

4}, P D Baade^{3

5}, D C Whiteman⁶, H P Soyer^{7

8}, M Janda⁹

¹ Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia.
² Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
³ Cancer Council Queensland, Brisbane, Australia.
⁴ Menzies Health Institute, Griffith University, Southport, QLD, Australia.
⁵ School of Mathematical Sciences, Queensland University of Technology, Brisbane, Australia.
⁶ QIMR-Berghofer Medical Research Institute, Brisbane, Australia.
⁷ Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia.
⁸ Dermatology Department, Princess Alexandra Hospital, Brisbane, Australia.
⁹ Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.

No abstract available

Comment on

Why a randomized melanoma screening trial is not a good idea.
Halvorsen JA, Løberg M, Gjersvik P, Roscher I, Veierød MB, Robsahm TE, Nilsen LTN, Kalager M, Bretthauer M. Halvorsen JA, et al. Br J Dermatol. 2018 Aug;179(2):532-533. doi: 10.1111/bjd.16784. Epub 2018 Jun 12. Br J Dermatol. 2018. PMID: 29893490 No abstract available.